Understanding factors influencing primary treatment with intradetrusor onabotulinumtoxinA versus augmentation cystoplasty in patients with spina bifida.
Neurourol Urodyn
; 42(6): 1431-1436, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37249147
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder, Neurogenic
/
Spinal Dysraphism
/
Meningomyelocele
/
Botulinum Toxins, Type A
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Neurourol Urodyn
Year:
2023
Type:
Article
Affiliation country:
United States